- Global Pharma News & Resources

Cells that could lead to new therapies: PromoCell now offers in vitro disease models

  • Portfolio extension: Wide range of donor cells with common chronic diseases
  • New models can help researchers investigate disease development and find new treatment approaches
  • Matched growth media are optimized for pharmaceutical drug discovery

Heidelberg, Germany, November 06, 2019 – PromoCell, a premier manufacturer of human primary cells and cell culture products, now offers cell disease models covering a wide range of diseases including diabetes type 1 and 2, respiratory diseases such as COPD and asthma, as well as cardiomyopathy disease. Relevant models enable experiments under physiologic conditions and are key for developing new therapies for chronic diseases. With its greater range of cell disease models, PromoCell once again underlines its role as a dedicated supporter of scientific research and innovation.

Large selection of donor cells with known disease status

“PromoCell now offers a large selection of donor cells with known disease status that are suitable for drug discovery and research applications,” says Daniel Spatz, CBO of PromoCell. These disease cell types can be cultured using PromoCell’s matching growth media to ensure optimal growth performance. “Our diseased cells feature the same specifications and undergo the same rigid quality control tests as their healthy counterparts from our human primary cell portfolio,” adds Dr. Irma Boercsoek, COO of PromoCell. The tests include cell factors marker characterization, growth performance and morphology.

Developing and testing potential treatment approaches

A cell disease model is an in vitro culture of cells isolated from a tissue donor with a known disease condition. By studying cell disease models, researchers gain insights in how diseases develop and this also enables them to look for new molecular targets for specific therapies. In addition, cell disease models can be used for testing potential treatment approaches. With its comprehensive portfolio of products and services for human cell culture, PromoCell supports scientists worldwide in advancing research and developing safer drugs.

To learn more about PromoCell’s cell disease models, visit or get in touch with their scientific support service at the toll-free number 0800 - 776 66 23.

Corporate information and press material:

Larissa Menescal
Tel.: +49 6221 649 34 0

About PromoCell
PromoCell GmbH, based in Heidelberg, Germany, is a biotech company that supplies researchers worldwide with tools and training for human primary cell culture and cell analysis. The company was founded in 1990.

Today, PromoCell offers more than 7,000 human cell culture and cell biology products. As part of the human cell culture portfolio, the company offers human primary cells, stem cells and blood cells, as well as optimized products for cancer cell culture, including kits for 3D cell culture. PromoCell’s cell biology products are used for in-depth analysis of cells in culture. The portfolio includes high-quality kits and reagents for cell biology, such as antibodies, ELISAs, cytokines, and growth factors.

As original manufacturer of all primary cells, stem cells and blood cells PromoCell is committed to the highest ethical and legal standards. When obtaining human tissue, the company strictly complies with European biomedical conventions, respects human rights, and protects donor privacy. Along with certified, high-quality products, PromoCell offers ISO certified professional training through its PromoCell Academy, founded in 2004. Find out more about PromoCell on the website or via its presence on FacebookYouTubeTwitter, or LinkedIn.

Editor Details

Last Updated: 08-Nov-2019